Mural Oncology(MURA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

MURA Mural Oncology

已收盘 11-25 16:00:00 EST

3.87

+0.52

+15.52%

盘后4.10

+0.23+5.94%

19:46 EST

最高4.26	最低3.77	成交量194.81万
今开3.99	昨收3.35	日振幅14.63%
总市值6,610万	流通市值5,337万	总股本1,708万
成交额787.37万	换手率14.13%	流通股本1,379万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"MURA","market":"US","secType":"STK","nameCN":"Mural Oncology","latestPrice":3.87,"timestamp":1732568400000,"preClose":3.35,"halted":0,"volume":1948101,"hourTrading":{"tag":"盘后","latestPrice":4.1,"preClose":3.87,"latestTime":"19:46 EST","volume":7279,"amount":29020.4537,"timestamp":1732581976892},"delay":0,"floatShares":13791629,"shares":17080352,"eps":-9.121025,"marketStatus":"已收盘","marketStatusCode":5,"change":0.52,"latestTime":"11-25 16:00:00 EST","open":3.9898,"high":4.26,"low":3.77,"amount":7873667.085113999,"amplitude":0.146269,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-9.121025,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1732611600000},"adr":0,"adjPreClose":3.35,"preHourTrading":{"tag":"盘前","latestPrice":3.98,"preClose":3.35,"latestTime":"09:29 EST","volume":53387,"amount":203746.6593152,"timestamp":1732544999143},"postHourTrading":{"tag":"盘后","latestPrice":4.1,"preClose":3.87,"latestTime":"19:46 EST","volume":7279,"amount":29020.4537,"timestamp":1732581976892},"volumeRatio":35.85616,"impliedVol":2.34,"impliedVolPercentile":0.6519},"requestUrl":"/m/hq/s/MURA","defaultTab":"news","newsList":[{"id":"2486038553","title":"Mural Oncology Plc股价飙升14.93% 市值涨980.63万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486038553","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486038553?lang=zh_cn&edition=full","pubTime":"2024-11-25 22:32","pubTimestamp":1732545126,"startTime":"0","endTime":"0","summary":"北京时间2024年11月25日22时32分，Mural Oncology Plc股票出现波动，股价急速上涨14.93%。截至发稿，该股报3.85美元/股，成交量30.9678万股，换手率1.82%，振幅5.07%。Mural Oncology Plc股票所在的生物技术行业中，整体涨幅为0.97%。Mural Oncology Plc公司简介：Mural Oncology PLC 是一家临床阶段的肿瘤公司，其整个业务都集中在发现和开发可能有意义地改善癌症患者生活的免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125223206a2548c5f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125223206a2548c5f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MURA","BK4139"],"gpt_icon":0},{"id":"2485713298","title":"Mural Oncology Plc2024财年第三财季实现净利润-31.76百万美元，同比增加38.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485713298","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485713298?lang=zh_cn&edition=full","pubTime":"2024-11-23 00:00","pubTimestamp":1732291216,"startTime":"0","endTime":"0","summary":"11月23日，Mural Oncology Plc公布财报，公告显示公司2024财年第三财季净利润为-31.76百万美元，同比增加38.07%；其中营业收入为0.00美元，每股基本收益为-1.87美元。从资产负债表来看，Mural Oncology Plc总负债29.13百万美元，其中短期债务5.44百万美元，资产负债比为0.07，流动比率为0.08。机构评级：截至2024年11月23日，当前有4家机构对Mural Oncology Plc目标价做出预测，其中目标均价为16.00美元，其中最低目标价为13.00美元，最高目标价为18.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123000035a24e4827&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123000035a24e4827&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MURA"],"gpt_icon":0},{"id":"2483045588","title":"Mural Oncology Plc盘中异动 股价大跌5.44%报3.30美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483045588","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483045588?lang=zh_cn&edition=full","pubTime":"2024-11-16 01:48","pubTimestamp":1731692885,"startTime":"0","endTime":"0","summary":"北京时间2024年11月16日01时48分，Mural Oncology Plc股票出现波动，股价快速下挫5.44%。截至发稿，该股报3.30美元/股，成交量10.0538万股，换手率0.59%，振幅4.30%。Mural Oncology Plc股票所在的生物技术行业中，整体跌幅为3.66%。Mural Oncology Plc公司简介：Mural Oncology PLC 是一家临床阶段的肿瘤公司，其整个业务都集中在发现和开发可能有意义地改善癌症患者生活的免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116014805abc54a62&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116014805abc54a62&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MURA","BK4139"],"gpt_icon":0},{"id":"2483038712","title":"Mural Oncology Plc盘中异动 大幅下挫5.25%报3.43美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483038712","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483038712?lang=zh_cn&edition=full","pubTime":"2024-11-13 00:25","pubTimestamp":1731428724,"startTime":"0","endTime":"0","summary":"北京时间2024年11月13日00时25分，Mural Oncology Plc股票出现波动，股价快速下挫5.25%。截至发稿，该股报3.43美元/股，成交量1.1212万股，换手率0.07%，振幅6.35%。Mural Oncology Plc股票所在的生物技术行业中，整体跌幅为0.71%。Mural Oncology Plc公司简介：Mural Oncology PLC 是一家临床阶段的肿瘤公司，其整个业务都集中在发现和开发可能有意义地改善癌症患者生活的免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113002524abba8c8f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113002524abba8c8f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MURA","BK4139"],"gpt_icon":0},{"id":"2482581034","title":"Mural Oncology Plc盘中异动 临近收盘股价大涨5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482581034","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482581034?lang=zh_cn&edition=full","pubTime":"2024-11-09 04:43","pubTimestamp":1731098629,"startTime":"0","endTime":"0","summary":"北京时间2024年11月09日04时43分，Mural Oncology Plc股票出现波动，股价急速拉升5.03%。截至发稿，该股报3.55美元/股，成交量7.5513万股，换手率0.44%，振幅5.46%。Mural Oncology Plc股票所在的生物技术行业中，整体涨幅为1.15%。Mural Oncology Plc公司简介：Mural Oncology PLC 是一家临床阶段的肿瘤公司，其整个业务都集中在发现和开发可能有意义地改善癌症患者生活的免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110904434998e418f7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110904434998e418f7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MURA","BK4139"],"gpt_icon":0},{"id":"2481053445","title":"Mural Oncology Plc盘中异动 大幅下跌6.07%报3.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481053445","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481053445?lang=zh_cn&edition=full","pubTime":"2024-11-05 01:40","pubTimestamp":1730742028,"startTime":"0","endTime":"0","summary":"北京时间2024年11月05日01时40分，Mural Oncology Plc股票出现异动，股价快速下挫6.07%。截至发稿，该股报3.25美元/股，成交量1.9107万股，换手率0.11%，振幅3.03%。Mural Oncology Plc股票所在的生物技术行业中，整体涨幅为0.00%。Mural Oncology Plc公司简介：Mural Oncology PLC 是一家临床阶段的肿瘤公司，其整个业务都集中在发现和开发可能有意义地改善癌症患者生活的免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241105014028a2159a3e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241105014028a2159a3e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MURA","BK4139"],"gpt_icon":0},{"id":"2477831550","title":"Mural Oncology Plc盘中异动 股价大跌5.18%报3.45美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477831550","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477831550?lang=zh_cn&edition=full","pubTime":"2024-10-24 02:09","pubTimestamp":1729706989,"startTime":"0","endTime":"0","summary":"北京时间2024年10月24日02时09分，Mural Oncology Plc股票出现波动，股价快速下挫5.18%。截至发稿，该股报3.45美元/股，成交量3.1728万股，换手率0.19%，振幅4.67%。Mural Oncology Plc股票所在的生物技术行业中，整体跌幅为1.49%。Mural Oncology Plc公司简介：Mural Oncology PLC 是一家临床阶段的肿瘤公司，其整个业务都集中在发现和开发可能有意义地改善癌症患者生活的免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241024020949ab6dfded&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241024020949ab6dfded&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MURA"],"gpt_icon":0},{"id":"2477690098","title":"Mural Oncology Plc盘中异动 早盘急速跳水5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477690098","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477690098?lang=zh_cn&edition=full","pubTime":"2024-10-21 22:23","pubTimestamp":1729520613,"startTime":"0","endTime":"0","summary":"北京时间2024年10月21日22时23分，Mural Oncology Plc股票出现波动，股价急速下挫5.21%。截至发稿，该股报3.46美元/股，成交量1.6097万股，换手率0.09%，振幅3.01%。Mural Oncology Plc股票所在的生物技术行业中，整体涨幅为0.07%。Mural Oncology Plc公司简介：Mural Oncology PLC 是一家临床阶段的肿瘤公司，其整个业务都集中在发现和开发可能有意义地改善癌症患者生活的免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241021222333971a164d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241021222333971a164d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MURA","BK4139"],"gpt_icon":0},{"id":"2476254209","title":"Mural Oncology Plc盘中异动 下午盘大幅拉升5.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2476254209","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476254209?lang=zh_cn&edition=full","pubTime":"2024-10-17 02:23","pubTimestamp":1729102996,"startTime":"0","endTime":"0","summary":"北京时间2024年10月17日02时23分，Mural Oncology Plc股票出现波动，股价急速上涨5.51%。截至发稿，该股报3.64美元/股，成交量3.8153万股，换手率0.22%，振幅4.93%。Mural Oncology Plc股票所在的生物技术行业中，整体跌幅为0.06%。Mural Oncology Plc公司简介：Mural Oncology PLC 是一家临床阶段的肿瘤公司，其整个业务都集中在发现和开发可能有意义地改善癌症患者生活的免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241017022316971a0afb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241017022316971a0afb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MURA","BK4139"],"gpt_icon":0},{"id":"2472461596","title":"Mural Oncology Plc盘中异动 大幅上涨5.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2472461596","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472461596?lang=zh_cn&edition=full","pubTime":"2024-10-04 00:28","pubTimestamp":1727972884,"startTime":"0","endTime":"0","summary":"北京时间2024年10月04日00时28分，Mural Oncology Plc股票出现波动，股价急速上涨5.45%。Mural Oncology Plc股票所在的生物技术行业中，整体跌幅为0.90%。Mural Oncology Plc公司简介：Mural Oncology PLC 是一家临床阶段的肿瘤公司，其整个业务都集中在发现和开发可能有意义地改善癌症患者生活的免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241004002804ab679cb1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241004002804ab679cb1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MURA","BK4139"],"gpt_icon":0},{"id":"2472334455","title":"Mural Oncology Plc盘中异动 下午盘大幅拉升5.12%报3.21美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2472334455","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472334455?lang=zh_cn&edition=full","pubTime":"2024-10-01 01:24","pubTimestamp":1727717075,"startTime":"0","endTime":"0","summary":"北京时间2024年10月01日01时24分，Mural Oncology Plc股票出现异动，股价大幅拉升5.12%。截至发稿，该股报3.21美元/股，成交量10.7917万股，换手率0.63%，振幅4.23%。Mural Oncology Plc股票所在的生物技术行业中，整体跌幅为0.43%。Mural Oncology Plc公司简介：Mural Oncology PLC 是一家临床阶段的肿瘤公司，其整个业务都集中在发现和开发可能有意义地改善癌症患者生活的免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100101243598e39e52&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100101243598e39e52&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MURA"],"gpt_icon":0},{"id":"2470768908","title":"Mural Oncology Plc盘中异动 下午盘急速下跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2470768908","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470768908?lang=zh_cn&edition=full","pubTime":"2024-09-27 01:36","pubTimestamp":1727372208,"startTime":"0","endTime":"0","summary":"北京时间2024年09月27日01时36分，Mural Oncology Plc股票出现异动，股价大幅跳水5.00%。截至发稿，该股报3.04美元/股，成交量3.717万股，换手率0.22%，振幅6.25%。Mural Oncology Plc股票所在的生物技术行业中，整体涨幅为0.29%。Mural Oncology Plc公司简介：Mural Oncology PLC 是一家临床阶段的肿瘤公司，其整个业务都集中在发现和开发可能有意义地改善癌症患者生活的免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240927013648ab6638fb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240927013648ab6638fb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MURA"],"gpt_icon":0},{"id":"2469140830","title":"Mural Oncology Plc盘中异动 股价大跌5.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2469140830","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469140830?lang=zh_cn&edition=full","pubTime":"2024-09-24 00:56","pubTimestamp":1727110588,"startTime":"0","endTime":"0","summary":"北京时间2024年09月24日00时56分，Mural Oncology Plc股票出现异动，股价大幅下跌5.33%。截至发稿，该股报3.20美元/股，成交量1.3923万股，换手率0.08%，振幅7.84%。Mural Oncology Plc股票所在的生物技术行业中，整体跌幅为2.28%。Mural Oncology Plc公司简介：Mural Oncology PLC 是一家临床阶段的肿瘤公司，其整个业务都集中在发现和开发可能有意义地改善癌症患者生活的免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240924005628ab65627b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240924005628ab65627b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MURA","BK4139"],"gpt_icon":0},{"id":"2460710305","title":"Mural Oncology Plc2024财年第二财季实现净利润-31.56百万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2460710305","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460710305?lang=zh_cn&edition=full","pubTime":"2024-08-19 00:03","pubTimestamp":1723996990,"startTime":"0","endTime":"0","summary":"8月19日，Mural Oncology Plc公布财报，公告显示公司2024财年第二财季净利润为-31.56百万美元；其中营业收入为0.00美元，每股基本收益为-1.87美元。从资产负债表来看，Mural Oncology Plc总负债30.36百万美元，其中短期债务5.35百万美元，资产负债比为0.08，流动比率为0.09。机构评级：截至2024年8月19日，当前有2家机构对Mural Oncology Plc目标价做出预测，其中目标均价为14.00美元，其中最低目标价为13.00美元，最高目标价为15.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081900032695a385c5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081900032695a385c5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MURA"],"gpt_icon":0},{"id":"2447638706","title":"Mural Oncology(MURA.US)获Rodman &amp; Renshaw首次覆盖，给予买入评级, 目标价15.","url":"https://stock-news.laohu8.com/highlight/detail?id=2447638706","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2447638706?lang=zh_cn&edition=full","pubTime":"2024-06-29 00:47","pubTimestamp":1719593256,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4139","MURA"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.muraloncology.com","stockEarnings":[{"period":"1week","weight":-0.029},{"period":"1month","weight":-0.029},{"period":"3month","weight":-0.0318},{"period":"6month","weight":-0.0669},{"period":"1year","weight":-0.051},{"period":"ytd","weight":-0.4341}],"compareEarnings":[{"period":"1week","weight":0.0167},{"period":"1month","weight":0.0303},{"period":"3month","weight":0.0594},{"period":"6month","weight":0.1248},{"period":"1year","weight":0.3088},{"period":"ytd","weight":0.2529}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Mural Oncology plc是一家爱尔兰注册公众有限公司，于2017年5月成立，是一家私人股份有限公司，2023年8月21日，该公司重新注册为公共有限公司，并更名为Mural Oncology plc。该公司是一家临床阶段的肿瘤学企业，专注于发现和开发可能有意义地改善癌症患者生活的免疫疗法。通过利用免疫细胞调节和蛋白质工程方面的核心能力，该公司开发了一系列新型的研究性细胞因子疗法，旨在解决多种癌症患者的需求未得到满足的领域。该公司的主要候选产品nemvaleukin alfa（简称“nemvaleukin”）是一种研究性、工程化的白细胞介素-2（简称“IL-2”）细胞因子，旨在捕获和扩大大剂量重组人IL-2（简称“rhIL-2”）的治疗益处，同时减轻其标志性毒性。","exchange":"NASDAQ","name":"Mural Oncology","nameEN":"Mural Oncology"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Mural Oncology(MURA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Mural Oncology(MURA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Mural Oncology,MURA,Mural Oncology股票,Mural Oncology股票老虎,Mural Oncology股票老虎国际,Mural Oncology行情,Mural Oncology股票行情,Mural Oncology股价,Mural Oncology股市,Mural Oncology股票价格,Mural Oncology股票交易,Mural Oncology股票购买,Mural Oncology股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Mural Oncology(MURA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Mural Oncology(MURA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}